Package Leaflet: Information for the User
Akeega 50 mg/500 mg film-coated tablets
niraparib/abiraterone acetate
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Akeega is a medicine that contains two active substances: niraparib and abiraterone acetate and works in two different ways.
Akeega is used to treat adult men with prostate cancer that has spread to other parts of the body and is no longer responding to medical or surgical treatment that lowers testosterone (also called castration-resistant metastatic prostate cancer).
Niraparib is a type of cancer medicine called a PARP inhibitor. PARP inhibitors block an enzyme called poly (adenosine diphosphate-ribose) polymerase (PARP). PARP helps cells to repair damaged DNA. When PARP is blocked, cancer cells cannot repair their DNA, which leads to the death of tumor cells and helps to control the cancer.
Abiraterone acetate stops the body from making testosterone; this can slow down the growth of prostate cancer.
When taking this medicine, your doctor will also prescribe another medicine called prednisone or prednisolone, to reduce the risk of high blood pressure, fluid retention, or low potassium levels in the blood.
Do not take Akeega:
Do not take this medicine if any of the above applies to you. If you are not sure, consult your doctor or pharmacist before taking this medicine.
Warnings and precautions
Talk to your doctor or pharmacist before starting to take this medicine or while taking this medicine if you have:
If any of the above applies to you (or you are not sure), talk to your doctor or pharmacist before taking this medicine.
If you have a low blood cell count for a long time while taking Akeega, this may be a sign of more serious problems with the bone marrow, such as myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Your doctor may want to examine your bone marrow to check for these problems.
Before starting to take Akeega, also talk to your doctor or pharmacist about:
If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking this medicine.
Blood tests
Akeega may affect your liver, but you may not notice any symptoms of liver problems. Therefore, while you are taking this medicine, your doctor will do regular blood tests to check for any effect on your liver.
Children and adolescents
This medicine must not be used in children or adolescents. If a child or adolescent accidentally swallows Akeega, take them to the hospital immediately and bring this leaflet with you to show to the emergency doctor.
Other medicines and Akeega
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This is because Akeega may affect the way other medicines work. Also, other medicines may affect the way Akeega works.
Treatment with medicines that stop the body from making testosterone may increase the risk of heart rhythm problems. Tell your doctor if you are taking medicines:
Talk to your doctor if you are taking any of the medicines listed above.
Taking Akeega with food
Pregnancy and breast-feeding
Akeega is not indicated in women.
Contraception for men using Akeega
Driving and using machines
Taking Akeega may make you feel weak, dizzy, tired, or faint. This could affect your ability to drive and use machines. Be careful when driving or using machines.
Akeega contains lactose and sodium
Follow exactly the instructions given to you by your doctor. If you are not sure, talk to your doctor or pharmacist.
How much to take
The recommended starting dose is 200 mg/1,000 mg once a day.
How to take Akeega
Your doctor may also prescribe other medicines while you are taking Akeega.
If you take more Akeega than you should
If you take more tablets than you should, contact your doctor. You may have a higher risk of side effects.
If you forget to take Akeega
If you forget to take Akeega or prednisone or prednisolone, take your normal dose as soon as you remember on the same day.
If you forget to take Akeega or prednisone or prednisolone for more than one day, talk to your doctor immediately.
Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
If you stop taking Akeega
Do not stop taking Akeega or prednisone or prednisolone unless your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Stop taking Akeega and seek medical help immediately if you have any of the following symptoms:
Very common(may affect more than 1 in 10 people)
Frequency not known(cannot be estimated from the available data) - not reported with the use of Akeega but reported with the use of niraparib or abiraterone acetate (components of Akeega)
Other side effects
If you experience any side effects, talk to your doctor. These include:
Very common(may affect more than 1 in 10 people):
Common(may affect up to 1 in 10 people):
Uncommon(may affect up to 1 in 100 people):
Frequency not known(cannot be estimated from the available data) - not reported with the use of Akeega but reported with the use of niraparib or abiraterone acetate (components of Akeega)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Akeega Composition
Product Appearance and Package Contents
Akeega film-coated tablets are orange-yellow or brown-yellow, oval in shape, with "N 50 A" engraved on one side and smooth on the other.
Each 28-day box contains 56 film-coated tablets in two cardboard boxes of 28 film-coated tablets each.
Marketing Authorization Holder
Janssen-Cilag International NV
Turnhoutseweg 30
B-2340 Beerse
Belgium
Manufacturer
Janssen Cilag SpA
Via C. Janssen,
Borgo San Michele
Latina 04100
Italy
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
België/Belgique/Belgien Janssen-Cilag NV Tel/Tél: +32 14 64 94 11 janssen@jacbe.jnj.com | Lietuva UAB "JOHNSON & JOHNSON" Tel: +370 5 278 68 88 lt@its.jnj.com |
jjsafety@its.jnj.com | Luxembourg/Luxemburg Janssen-Cilag NV Tél/Tel: +32 14 64 94 11 janssen@jacbe.jnj.com |
Ceská republika Janssen-Cilag s.r.o. Tel: +420 227 012 227 | Magyarország Janssen-Cilag Kft. Tel.: +36 1 884 2858 janssenhu@its.jnj.com |
Danmark Janssen-Cilag A/S Tlf: +45 4594 8282 jacdk@its.jnj.com | Malta AM MANGION LTD Tel: +356 2397 6000 |
Deutschland Janssen-Cilag GmbH Tel: +49 2137 955 955 jancil@its.jnj.com | Nederland Janssen-Cilag B.V. Tel: +31 76 711 1111 janssen@jacnl.jnj.com |
Eesti UAB "JOHNSON & JOHNSON" Eesti filiaal Tel: +372 617 7410 ee@its.jnj.com | Norge Janssen-Cilag AS Tlf: +47 24 12 65 00 jacno@its.jnj.com |
Ελλáδα Janssen-Cilag Φαρμακευτικ? Α.Ε.Β.Ε. Tηλ: +30 210 80 90 000 | Österreich Janssen-Cilag Pharma GmbH Tel: +43 1 610 300 |
España Janssen-Cilag, S.A. Tel: +34 91 722 81 00 contacto@its.jnj.com | Polska Janssen-Cilag Polska Sp. z o.o. Tel.: +48 22 237 60 00 |
France Janssen-Cilag Tél: 0 800 25 50 75 / +33 1 55 00 40 03 medisource@its.jnj.com | Portugal Janssen-Cilag Farmacêutica, Lda. Tel: +351 214 368 600 |
Hrvatska Johnson & Johnson S.E. d.o.o. Tel: +385 1 6610 700 jjsafety@JNJCR.JNJ.com | România Johnson & Johnson România SRL Tel: +40 21 207 1800 |
Ireland Janssen Sciences Ireland UC Tel: +353 1 800 709 122 | Slovenija Johnson & Johnson d.o.o. Tel: +386 1 401 18 00 Janssen_safety_slo@its.jnj.com |
Ísland Janssen-Cilag AB c/o Vistor hf. Sími: +354 535 7000 janssen@vistor.is | Slovenská republika Johnson & Johnson, s.r.o. Tel: +421 232 408 400 |
Italia Janssen-Cilag SpA Tel: 800.688.777 / +39 02 2510 1 janssenita@its.jnj.com | Suomi/Finland Janssen-Cilag Oy Puh/Tel: +358 207 531 300 jacfi@its.jnj.com |
Sverige Janssen-Cilag AB Tfn: +46 8 626 50 00 jacse@its.jnj.com | |
Latvija UAB "JOHNSON & JOHNSON" filiale Latvija Tel: +371 678 93561 lv@its.jnj.com | United Kingdom (Northern Ireland) Janssen Sciences Ireland UC Tel: +44 1 494 567 444 |
Date of Last Revision of this Leaflet: MM/AAAA.
Other Sources of Information
Detailed information on this medication is available on the European Medicines Agency website: http://www.ema.europa.eu.